Showing results (41-50 of 715) with videos related to
Sort By:
Pageof 72
European Journal of Nuclear Medicine and Molecular Imaging|February 15, 2021
First-in-human neuroimaging of soluble epoxide hydrolase using [18F]FNDP PETJennifer M Coughlin, Stephanie Slania, Yong Du, et al.Clinical Nuclear Medicine|January 23, 2018
Flare on Serial Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT Examinations in Castration-Resistant Prostate Cancer: First ObservationsKatherine A Zukotynski, John Valliant, François Bénard, et al.Abdominal Radiology (New York)|August 2, 2022
Photorealistic three-dimensional visualization of fusion datasets: cinematic rendering of PET/CTSteven P Rowe, Martin G Pomper, Jeffrey P Leal, et al.Angewandte Chemie (International Ed. in English)|August 31, 2016
Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose ConjugationQing-Li He, Il Minn, Qiaoling Wang, et al.Advances in Cancer Research|October 8, 2014
Molecular-genetic imaging of cancerIl Minn, Mitchell E Menezes, Siddik Sarkar, et al.Magnetic Resonance in Medicine|April 29, 2015
Tumor-specific expression and detection of a CEST reporter geneIl Minn, Amnon Bar-Shir, Keerthi Yarlagadda, et al.Scientific Reports|March 30, 2021
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profileSrikanth Boinapally, Hye-Hyun Ahn, Bei Cheng, et al.Nuclear Medicine Communications|July 14, 2017
Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsiMichael A Gorin, Wael Marashdeh, Ashley E Ross, et al.Seminars in Nuclear Medicine|May 26, 2023
Role of Functional SPECT and PET in Renal EmergenciesTakahiro Higuchi, Philipp E Hartrampf, Andreas K Buck, et al.Journal of Clinical Medicine|July 24, 2019
Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CTRudolf A Werner, James T Thackeray, Martin G Pomper, et al.Pageof 72